PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $12,573,000 | -11.7% | 1,246,121 | -8.7% | 2.28% | +64.4% |
Q2 2020 | $14,241,000 | +110.9% | 1,365,376 | +70.7% | 1.38% | +46.0% |
Q1 2020 | $6,752,000 | +120.9% | 800,000 | +129.0% | 0.95% | +159.7% |
Q4 2019 | $3,057,000 | -18.7% | 349,400 | 0.0% | 0.36% | -43.2% |
Q3 2019 | $3,761,000 | -15.3% | 349,400 | 0.0% | 0.64% | +7.2% |
Q2 2019 | $4,441,000 | -67.2% | 349,400 | 0.0% | 0.60% | -76.0% |
Q1 2019 | $13,553,000 | +169.2% | 349,400 | +41.2% | 2.50% | +116.2% |
Q4 2018 | $5,035,000 | – | 247,400 | – | 1.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |